These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 1746586)
61. Treatment of cancer anorexia with megestrol acetate: which is the optimal dose? Feliu J; González-Barón M; Berrocal A; Ordóñez A; Barón-Saura JM J Natl Cancer Inst; 1991 Mar; 83(6):449-50. PubMed ID: 1999853 [No Abstract] [Full Text] [Related]
62. Endocrinologic and metabolic manifestations of the acquired immunodeficiency syndrome. Poretsky L; Maran A; Zumoff B Mt Sinai J Med; 1990 Sep; 57(4):236-41. PubMed ID: 2247101 [TBL] [Abstract][Full Text] [Related]
63. Megestrol acetate for cancer anorexia/cachexia #100. Salacz ME J Palliat Med; 2006 Jun; 9(3):803-4. PubMed ID: 16812940 [No Abstract] [Full Text] [Related]
64. Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer. Bonomi P; Pessis D; Bunting N; Block M; Anderson K; Wolter J; Rossof A; Slayton R; Harris J Semin Oncol; 1985 Mar; 12(1 Suppl 1):36-9. PubMed ID: 3975650 [TBL] [Abstract][Full Text] [Related]
65. Wasting syndrome--affordable treatments. James JS AIDS Treat News; 1995 Jul; (no 226):6-7. PubMed ID: 11362615 [TBL] [Abstract][Full Text] [Related]
66. [Current views on use of megestrol acetate in oncology practice]. Vyzula R Vnitr Lek; 1997 Apr; 43(4):250-5. PubMed ID: 9601846 [TBL] [Abstract][Full Text] [Related]
67. Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study. Bruera E; Ernst S; Hagen N; Spachynski K; Belzile M; Hanson J; Summers N; Brown B; Dulude H; Gallant G Cancer Prev Control; 1998 Apr; 2(2):74-8. PubMed ID: 9765767 [TBL] [Abstract][Full Text] [Related]
68. Megestrol acetate flare. Greenwald ES Cancer Treat Rep; 1983 Apr; 67(4):405. PubMed ID: 6850658 [No Abstract] [Full Text] [Related]
69. Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome. Dawson NA; McLeod DG J Urol; 1995 Jun; 153(6):1946-7. PubMed ID: 7538601 [TBL] [Abstract][Full Text] [Related]
70. Use of megestrol acetate in cats. Romatowski J J Am Vet Med Assoc; 1989 Mar; 194(5):700-2. PubMed ID: 2647696 [No Abstract] [Full Text] [Related]
71. Front-line hormonal therapy for patients with advanced breast cancer: a community oncology research program. Smalley RV; Sigal RB; Anderson S Semin Oncol; 1990 Dec; 17(6 Suppl 9):47-51. PubMed ID: 2259926 [TBL] [Abstract][Full Text] [Related]
74. Lessons from spending on megestrol for cancer cachexia. Brown TJ; Gandhi S; Smith TJ; Gupta A Support Care Cancer; 2021 Oct; 29(10):5553-5555. PubMed ID: 33893560 [No Abstract] [Full Text] [Related]
75. Ten years of Croatian national guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome - Evaluation of awareness and implementation among Croatian oncologists. Krznaric Ž; Juretic A; Domislovic V; Barisic A; Kekez D; Vranesic Bender D Clin Nutr ESPEN; 2019 Oct; 33():202-206. PubMed ID: 31451262 [TBL] [Abstract][Full Text] [Related]
76. Megestrol acetate for the prevention of hot flashes. Hughes-Davies TH N Engl J Med; 1995 Jan; 332(1):64. PubMed ID: 7864968 [No Abstract] [Full Text] [Related]
77. [Value of acetate medroxyprogesterone in the treatment of cachexia in AIDS]. Saint-Marc T; Livrozet JM; Fournier F; Rambeaud B; Touraine JL Presse Med; 1993 Apr; 22(12):597. PubMed ID: 8511098 [No Abstract] [Full Text] [Related]
78. Hyperglycemia induced by megestrol acetate. Panwalker AP Ann Intern Med; 1992 May; 116(10):878. PubMed ID: 1567110 [No Abstract] [Full Text] [Related]